BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26535788)

  • 1. Combined High-Density Lipoprotein Proteomic and Glycomic Profiles in Patients at Risk for Coronary Artery Disease.
    Krishnan S; Huang J; Lee H; Guerrero A; Berglund L; Anuurad E; Lebrilla CB; Zivkovic AM
    J Proteome Res; 2015 Dec; 14(12):5109-18. PubMed ID: 26535788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.
    Natarajan P; Collier TS; Jin Z; Lyass A; Li Y; Ibrahim NE; Mukai R; McCarthy CP; Massaro JM; D'Agostino RB; Gaggin HK; Bystrom C; Penn MS; Januzzi JL
    J Am Coll Cardiol; 2019 May; 73(17):2135-2145. PubMed ID: 31047001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
    Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
    Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of fibroblast growth factor 23 and fetuin--A to coronary atherosclerosis.
    Akin F; Celik O; Altun I; Ayca B; Diker VO; Satılmıs S; Sahin C
    J Diabetes Complications; 2015; 29(4):550-5. PubMed ID: 25772252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.
    Alwaili K; Bailey D; Awan Z; Bailey SD; Ruel I; Hafiane A; Krimbou L; Laboissiere S; Genest J
    Biochim Biophys Acta; 2012 Mar; 1821(3):405-15. PubMed ID: 21840418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.
    Agarwala AP; Rodrigues A; Risman M; McCoy M; Trindade K; Qu L; Cuchel M; Billheimer J; Rader DJ
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1515-9. PubMed ID: 25838421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
    Sattler K; Gräler M; Keul P; Weske S; Reimann CM; Jindrová H; Kleinbongard P; Sabbadini R; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
    J Am Coll Cardiol; 2015 Sep; 66(13):1470-85. PubMed ID: 26403344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.
    Sutter I; Velagapudi S; Othman A; Riwanto M; Manz J; Rohrer L; Rentsch K; Hornemann T; Landmesser U; von Eckardstein A
    Atherosclerosis; 2015 Aug; 241(2):539-46. PubMed ID: 26093887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis.
    Saku K; Zhang B; Ohta T; Arakawa K
    J Am Coll Cardiol; 1999 Feb; 33(2):436-43. PubMed ID: 9973024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.
    Patel PJ; Khera AV; Jafri K; Wilensky RL; Rader DJ
    J Am Coll Cardiol; 2011 Nov; 58(20):2068-75. PubMed ID: 22051328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein subclass profile and mortality in patients with coronary artery disease: Results from the GENES study.
    Elbaz M; Faccini J; Bongard V; Ingueneau C; Taraszkiewicz D; Perret B; Ferrières J; Ruidavets JB; Vindis C
    Arch Cardiovasc Dis; 2016 Nov; 109(11):607-617. PubMed ID: 27693051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.
    Krychtiuk KA; Kastl SP; Pfaffenberger S; Pongratz T; Hofbauer SL; Wonnerth A; Katsaros KM; Goliasch G; Gaspar L; Huber K; Maurer G; Dostal E; Oravec S; Wojta J; Speidl WS
    Atherosclerosis; 2014 Dec; 237(2):589-96. PubMed ID: 25463093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
    Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
    Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma high density lipoproteins and coronary artery disease.
    Sodhi HS; Lee G; Joye JA; Clifford CK; Kudchodkar BJ; Terai Y; Shaw I; Mason DT
    Adv Myocardiol; 1980; 2():513-25. PubMed ID: 7423063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.
    Riwanto M; Rohrer L; Roschitzki B; Besler C; Mocharla P; Mueller M; Perisa D; Heinrich K; Altwegg L; von Eckardstein A; Lüscher TF; Landmesser U
    Circulation; 2013 Feb; 127(8):891-904. PubMed ID: 23349247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study [corrected].
    Schaffer A; Verdoia M; Cassetti E; Barbieri L; Perrone-Filardi P; Marino P; De Luca G
    J Thromb Thrombolysis; 2015 Jul; 40(1):61-8. PubMed ID: 25680891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copeptin predicts coronary artery disease cardiovascular and total mortality.
    Tasevska I; Enhörning S; Persson M; Nilsson PM; Melander O
    Heart; 2016 Jan; 102(2):127-32. PubMed ID: 26661323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
    Wang G; Mathew AV; Yu H; Li L; He L; Gao W; Liu X; Guo Y; Byun J; Zhang J; Chen YE; Pennathur S
    PLoS One; 2018; 13(3):e0193782. PubMed ID: 29505607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waist-hip ratio and low HDL predict the risk of coronary artery disease in Pakistanis.
    Nishtar S; Wierzbicki AS; Lumb PJ; Lambert-Hammill M; Turner CN; Crook MA; Mattu MA; Shahab S; Badar A; Ehsan A; Marber MS; Gill J
    Curr Med Res Opin; 2004 Jan; 20(1):55-62. PubMed ID: 14741073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.